Activin A, a member of the
transforming growth factor (
TGF)-beta superfamily, is involved in regulation of tissue remodeling and
inflammation. Herein, we wanted to explore a role for
activin A in
pulmonary hypertension (PH). Circulating levels of
activin A and its
binding protein follistatin were measured in patients with PH (n = 47) and control subjects (n = 14). To investigate synthesis and localization of pulmonary
activin A, we utilized an experimental model of
hypoxia-induced PH. In mouse lungs, we also explored signaling pathways that can be activated by
activin A, such as phosphorylation of Smads, which are mediators of
TGF-beta signaling. Possible pathophysiological mechanisms initiated by
activin A were explored by exposing pulmonary arterial smooth muscle cells in culture to this
cytokine. Elevated levels of
activin A and
follistatin were found in patients with PH, and
activin A levels were significantly related to mortality. Immunohistochemistry of lung autopsies from PH patients and lungs with experimental PH localized
activin A primarily to alveolar macrophages and bronchial epithelial cells. Mice with PH exhibited increased pulmonary levels of
mRNA for
activin A and
follistatin in the lungs, and also elevated pulmonary levels of phosphorylated Smad2. Finally, we found that
activin A increased proliferation and induced gene expression of
endothelin-1 and
plasminogen activator inhibitor-1 in pulmonary artery smooth muscle cells, mediators that could contribute to
vascular remodeling. Our findings in both clinical and experimental studies suggest a role for
activin A in the development of various types of PH.